The Rosetta stone for deciphering the cell signaling language critical to develop novel therapies.
Advanced integration of biological systems, math models and artificial intelligence.
InterAx combines machine learning, mathematical modeling of cellular processes, and experimental methods derived from more than 15 years of fundamental research to generate high-efficacy leads for a given GPCR target.
InterAx technology platform creates lead molecules and drug candidates with uniquely high efficacy and safety (extended therapeutic window), along with exceptionally differentiated paths for IP protection. This drug discovery platform joins together state-of-the-art experimental biology, mathematical biology, computational chemistry and ML and AI to decode the cellular communication language and thereby create uniquely efficacious drugs.
InterAx uses Mechanistic models to create drugs with unique therapeutic profiles
Our Pipeline
InterAx is building a pipeline of drug candidates with superior efficacy and tolerability
With Support From
